본문으로 바로가기

행사/교육

World Drug Safety Congress Americas 2013

  • 등록일2013-02-19
  • 조회수4018
  • 구분 국외
  • 행사교육분류 행사
  • 주관기관
    Health Network Communications Ltd
  • 행사장소
    Revere Hotel - Boston Common - Boston
  • 행사기간
    2013-04-24 ~ 2013-04-25
  • 원문링크
  • 첨부파일

 

World Drug Safety Congress Americas 2013

 

conference programme



Day One - Wednesday 24th April 2013

 

Safety Signal Management Strategies


8.30am Opening Remarks from the Chair 


8.45am How to achieve drug safety excellence in today’s challenging industry environment 


GLOBAL SAFETY DRIVERS


9.15am USA drug safety regulatory update

• Review of the drug safety regulatory backdrop in the US and resulting impact on global operations

• FDA MeEdWatch: The FDA Safety Information and Adverse Event Reporting Program

• Investigational New Drug Safety Reporting Requirements

• Sentinel initiative › Dr José Vega, Vice President Global Safety, Amgen


USA drug safety regulatory update


9.45am PANEL DISCUSSION: Can the industry achieve global harmonisation in a local-level focussed regulatory system?
› David Balderson, Executive Director, Safety Operations, Amgen› Philip Miner, Director, Safety Alliance Management, Forest Laboratories Inc PANEL DISCUSSION: Can the industry achieve global harmonisation in a local-level focussed regulatory system?


10.15am Speed networking followed by refreshments  
 


BENEFIT RISK MANAGEMENT

 

11am The benefit risk mindset & evolving management strategies


11.30am Assessing the effectiveness of Risk Management Plans and REMS

12pm Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business 


12.30pm Social Media, Digitized Healthcare Data, and The Future of Drug Safety

 

1pm Lunch

 

SAFETY SIGNAL MANAGEMENT STRATEGIES

 

2pm Signal detection strategies through the lifecycle: advancing the science, ensuring compliance, protecting patients


 

2.30pm An organizational approach to safety review teams and signal tracking for better benefit risk governance


3pm Analysis and evaluation of signals in practice


3.30pm Setting up a signal detection unit in an emerging market


4pm Afternoon Refreshments 


 

4.30pm Inspection Preparedness


5pm Benefit risk communication strategies for key stakeholders


5.30pm Case study: Designing a pharmacovigilance and risk plan for therapeutic area specific drugs


6pm Networking Drinks Reception 

 

Data Management Tools & Techniques

 

8.30am Opening Remarks from the Chair 


8.45am How to achieve drug safety excellence in today’s challenging industry environment 


GLOBAL SAFETY DRIVERS


9.15am USA drug safety regulatory update

• Review of the drug safety regulatory backdrop in the US and resulting impact on global operations

• FDA MeEdWatch: The FDA Safety Information and Adverse Event Reporting Program

• Investigational New Drug Safety Reporting Requirements

• Sentinel initiative
› Dr José Vega, Vice President Global Safety, Amgen USA drug safety regulatory update


 

9.45am PANEL DISCUSSION: Can the industry achieve global harmonisation in a local-level focussed regulatory system?
› David Balderson, Executive Director, Safety Operations, Amgen› Philip Miner, Director, Safety Alliance Management, Forest Laboratories Inc
PANEL DISCUSSION: Can the industry achieve global harmonisation in a local-level focussed regulatory system?

 

10.15am Speed networking followed by refreshments 


 

BENEFIT RISK MANAGEMENT

 

11am The benefit risk mindset & evolving management strategies


11.30am Assessing the effectiveness of Risk Management Plans and REMS


12pm Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business


12.30pm Social Media, Digitized Healthcare Data, and The Future of Drug Safety


1pm Lunch

 

DATA MANAGEMENT TOOLS & TECHNIQUES


2pm Determining the extent of safety data needed to satisfy regulatory and internal needs


 

2.30pm Safety Data Exchange Agreements for co-marketed/licensed products


3pm Application of data mining techniques to aid signal detection


3.30pm Safety data review tools and technologies


4pm Afternoon Refreshments 


4.30pm Inspection Preparedness


5pm Benefit risk communication strategies for key stakeholders


5.30pm Case study: Designing a pharmacovigilance and risk plan for therapeutic area specific drugs


 

6pm Networking Drinks Reception 

 

 

........(계속)

 

 

☞ 자세한 내용은 내용바로가기를 이용하시기 바랍니다.